Huma, a prominent digital health company, has recently announced that its Software as a Medical Device (SaMD) platform has received Class II clearance from the U.S. Food and Drug Administration (FDA). This significant milestone allows Huma to provide its disease-agnostic platform for monitoring patients of all ages, including pediatrics and pregnancy, regardless of their condition. […]
The post FDA Approves Huma’s Software as a Medical Device (SaMD) Platform appeared first on ReadWrite.
View Article on ReadWrite
AI,News,ReadWrite,Software
Software